For citations:

Morinaka A..., Tsutsumi Y..., Yamada M..., Suzuki K..., Watanabe T..., Abe T..., Furuuchi T..., Inamura S..., Sakamaki Y..., Mitsuhashi N..., Ida T..., Livermore D.M. OP0595, A NEW DIAZABICYCLOOCTANE: MODE OF ACTION AS A SERINE β-LACTAMASE INHIBITOR, ANTIBIOTIC AND β-LACTAM 'ENHANCER'. Antibiot Khimioter = Antibiotics and Chemotherapy. 2015;60(11-12):51-52. (In Russ.)